NCT06794229 · Interventional trial
Neoadjuvant Zanzalintinib Plus Nivolumab in Patients With Locally Advanced and/or Inoperable Clear Cell Renal Cell Carcinoma With or Without Non-measurable Metastasis
Overall registry status Recruiting
Phase 2
Conditions Locally Advanced Renal Cell Carcinoma
Delaware Valley sites
- Fox Chase Cancer Center · Philadelphia, PA · Philadelphia County · Active not recruiting
First posted
Registry updated
Added to the directory